| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Social justice and disadvantaged groups.
|
Hastings Cent Rep
|
2007
|
3.72
|
|
2
|
rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers.
|
J Infect Dis
|
2005
|
2.46
|
|
3
|
Risk factors for severe respiratory syncytial virus infection among Alaska native children.
|
Pediatrics
|
2002
|
2.46
|
|
4
|
A role for immune complexes in enhanced respiratory syncytial virus disease.
|
J Exp Med
|
2002
|
2.34
|
|
5
|
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.
|
MMWR Morb Mortal Wkly Rep
|
2014
|
1.97
|
|
6
|
The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study.
|
Clin Infect Dis
|
2012
|
1.78
|
|
7
|
The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
|
Vaccine
|
2007
|
1.68
|
|
8
|
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.
|
MMWR Morb Mortal Wkly Rep
|
2015
|
1.64
|
|
9
|
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
|
Vaccine
|
2009
|
1.56
|
|
10
|
Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.
|
J Infect Dis
|
2004
|
1.51
|
|
11
|
Laboratory methods for determining pneumonia etiology in children.
|
Clin Infect Dis
|
2012
|
1.38
|
|
12
|
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.
|
Proc Natl Acad Sci U S A
|
2005
|
1.36
|
|
13
|
Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness.
|
J Clin Microbiol
|
2007
|
1.34
|
|
14
|
Prevention and Control of Seasonal Influenza with Vaccines.
|
MMWR Recomm Rep
|
2016
|
1.32
|
|
15
|
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
|
Pediatr Infect Dis J
|
2003
|
1.32
|
|
16
|
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.
|
J Infect Dis
|
2006
|
1.30
|
|
17
|
Breathing new life into pneumonia diagnostics.
|
J Clin Microbiol
|
2009
|
1.28
|
|
18
|
Specimen collection for the diagnosis of pediatric pneumonia.
|
Clin Infect Dis
|
2012
|
1.26
|
|
19
|
Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.
|
J Infect Dis
|
2011
|
1.25
|
|
20
|
Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus.
|
Clin Diagn Lab Immunol
|
2002
|
1.22
|
|
21
|
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.
|
Clin Infect Dis
|
2003
|
1.20
|
|
22
|
A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.
|
J Infect Dis
|
2010
|
1.18
|
|
23
|
The future of respiratory syncytial virus vaccine development.
|
Pediatr Infect Dis J
|
2004
|
1.17
|
|
24
|
Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
|
J Infect Dis
|
2008
|
1.14
|
|
25
|
The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.
|
J Infect Dis
|
2006
|
1.06
|
|
26
|
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
|
J Infect Dis
|
2004
|
1.04
|
|
27
|
An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
|
Influenza Other Respir Viruses
|
2012
|
1.03
|
|
28
|
Progress in the development of human parainfluenza virus vaccines.
|
Expert Rev Respir Med
|
2011
|
1.03
|
|
29
|
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.
|
J Infect Dis
|
2004
|
1.02
|
|
30
|
Use and evaluation of molecular diagnostics for pneumonia etiology studies.
|
Clin Infect Dis
|
2012
|
1.00
|
|
31
|
A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.
|
J Infect Dis
|
2005
|
0.99
|
|
32
|
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
|
Vaccine
|
2011
|
0.99
|
|
33
|
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.
|
J Infect Dis
|
2004
|
0.98
|
|
34
|
Disk diffusion bioassays for the detection of antibiotic activity in body fluids: applications for the Pneumonia Etiology Research for Child Health project.
|
Clin Infect Dis
|
2012
|
0.97
|
|
35
|
C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.
|
J Virol
|
2006
|
0.96
|
|
36
|
Comparison of temple temperatures with rectal temperatures in children under two years of age.
|
Clin Pediatr (Phila)
|
2002
|
0.94
|
|
37
|
Pneumonia etiology research for child health. Introduction.
|
Clin Infect Dis
|
2012
|
0.89
|
|
38
|
Public health and biosecurity. The obligation to prevent the next dual-use controversy.
|
Science
|
2012
|
0.88
|
|
39
|
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
|
Vaccine
|
2013
|
0.87
|
|
40
|
Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.
|
Vaccine
|
2005
|
0.86
|
|
41
|
Respiratory syncytial virus infection in Navajo and White Mountain Apache children.
|
Pediatrics
|
2002
|
0.86
|
|
42
|
Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens.
|
J Microbiol Methods
|
2014
|
0.86
|
|
43
|
Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.
|
Am J Transplant
|
2015
|
0.81
|
|
44
|
Evaluation of pneumonia virus of mice as a possible human pathogen.
|
J Virol
|
2012
|
0.80
|
|
45
|
Experimental infection of adults with recombinant wild-type human metapneumovirus.
|
J Infect Dis
|
2013
|
0.79
|
|
46
|
The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma.
|
Pediatr Infect Dis J
|
2016
|
0.75
|